NanoFynd Pty Ltd
Overview
NanoFynd is an innovative Australian company specialising in the development and commercialisation of advanced nanotechnology-based biosensors. Our core technology leverages a unique nanostructured chip composed of porous silicon semiconductor with a fluorocarbon polymeric nanocoating. This platform significantly enhances the detection and analysis of complex biological samples, providing highly sensitive, rapid, point of collection confirmatory test results.
Core Technology:- Nanostructured Biosensor Chip: A porous silicon semiconductor with a fluorocarbon polymeric nanocoating designed for enhanced surface area and superior analyte retention.
- Detection Method: Utilizes advanced mass spectrometry techniques, such as MALDI MS (Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry), for precise biomolecular analysis.
- High Sensitivity and Specificity: The nanostructured surface allows for greater analyte retention, resulting in highly sensitive detection, even at low concentrations.
- Rapid Analysis: Enables fast and efficient testing processes, crucial in time-sensitive applications such as law enforcement and clinical diagnostics.
- Versatile Application: Capable of analysing a wide range of substances, from illicit drugs to disease biomarkers, making it adaptable to various sectors including forensic science, healthcare, and veterinary diagnostics.
- Enhanced Data Accuracy: Provides robust and reliable results, reducing false positives/negatives and increasing confidence in the outcomes.
- Scalability: The technology can be scaled for both small-scale and large-scale applications, ensuring flexibility in deployment.
NanoFynd's biosensor technology addresses several critical challenges in substance testing:
- Illicit Drug Detection: Traditional methods often require extensive sample preparation and lengthy analysis times. NanoFynd’s technology streamlines the process, delivering rapid and accurate results, which is vital for law enforcement and forensic labs.
- Point-of-Need Testing: The portability and speed of the biosensors allow for on-site testing in various environments, such as field testing for drugs or contaminants, reducing the need for centralized lab facilities.
- Multi-Analyte Detection: Capable of simultaneously detecting multiple substances, improving efficiency and reducing costs associated with testing multiple samples separately.
- Reliability in Complex Matrices: Effective in complex biological matrices (e.g., blood, saliva), providing reliable results where traditional methods may struggle.
- Target Industries: Agriculture, Veterinary, Law Enforcement, Government Agencies, Private Companies, and High Volume High Risk workplaces e.g. Mining, Aviation, Transportation.
- Applications: Primarily focused on diagnostics, including illicit drug detection, disease biomarker identification, and other critical applications in forensic and clinical settings.
Market Opportunity
Proin auctor bibendum ex, non condimentum tortor sodales vitae. Ut feugiat at lorem accumsan consequat.
Suspendisse ac condimentum ipsum, sit amet auctor dui. Aliquam pretium justo in commodo varius.
Pellentesque elementum felis non urna vulputate, non posuere metus suscipit.
Aenean lacinia id quam a lobortis. Cras nibh lorem, vulputate eget purus elementum, pharetra condimentum elit.
Quisque et sagittis ex, vitae ultrices nulla. Vivamus dapibus blandit libero, et scelerisque dui ullamcorper ut.
Open an account to get
access to more details
Competitive Advantage
Cras eleifend purus vitae mattis imperdiet.
Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.
Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.
Fusce scelerisque massa sit amet turpis rutrum semper.
Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.
Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.
Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla l
Open an account to get
access to more details
Problem and Solution
Proin auctor bibendum ex, non condimentum tortor sodales vitae. Ut feugiat at lorem accumsan consequat.
Suspendisse ac condimentum ipsum, sit amet auctor dui. Aliquam pretium justo in commodo varius.
Pellentesque elementum felis non urna vulputate, non posuere metus suscipit.
Aenean lacinia id quam a lobortis. Cras nibh lorem, vulputate eget purus elementum, pharetra condimentum elit.
Quisque et sagittis ex, vitae ultrices nulla. Vivamus dapibus blandit libero, et scelerisque dui ullamcorper ut. Vivamus ut molestie ex. Integer eget tempus mauris. Quisque volutpat pulvinar urna, posuere pharetra ex auctor vel. Sed id lacus tortor. Proin nisl turpis, tempus a leo in, lacinia volutpat orci.
Aenean nulla nibh, porta a dignissim vitae, laoreet vitae lacus. Nunc in aliquet urna. Vivamus vel turpis a mi consequat venenatis. Pellentesque tincidunt ante ut urna accumsan lacinia. Sed sed enim volutpat, malesuada metus ut, lobortis lectus. Sed vulputate fringilla justo, sed condimentum tellus fermentum sit amet. Pellentesque tempus elit id dapibus ornare. Phasellus a
Open an account to get
access to more details
Investment Offering
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat, ornare lorem a, vulput
Open an account to get
access to more details
See more exiting opportunities on CapitalHQ
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...
ProxyTwin
ProxyTwin™ amplifies expertise. ProxyTwin is a digital twin that works for experts so they can help more people. We create advanced digital replicas of real individuals, enabling them to virtually attend meetings, deliver messages, and hold thousands of interactions simultaneously. Recently...
HorizonTwo Capital Partners
HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.
The Insides Company
First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.
DCARB
We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.
Grabba Technologies Pty Ltd
Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.
Backed By Leading Investment Groups and Family Offices
